A number of reports released last week show that cases of chlamydia, gonorrhea, and syphilis are increasing in states and localities across the United States.
This week, there are new recommendations for chlamydia and gonorrhea screening for young women, a secret shopper study found that young men may have a harder time buying EC over the counter, and Kansas seizes sex toys.
The rise of antibiotic-resistant bacteria is a looming public health crisis. Last week, the White House simultaneously released a national strategy, a report, and an executive order from the president that takes aim at this issue.
This week, a new study presents evidence that the parasite that causes trich might lead to prostate cancer, a new list shows the best and worst states for STIs, a Gallup poll shows the most support ever for same-sex marriage, and gay rights activist Harvey Milk is honored with a stamp.
Expedited partner therapy is now legal in Washington, D.C., thanks to the passage of Bill 20-343. It’s a progressive step for a medical practice whose day is long overdue.
The Centers for Disease Control and Prevention has released sexually transmitted disease surveillance data for 2012, and the news is not good: Cases of chlamydia, gonorrhea, and syphilis all continued to rise.
A new website asks members to sign up for frequent STD testing and lets them share their results with other members confidentially. Encouraging STD testing is a good thing, but the site has major flaws. And when it comes to STDs, I can’t help but wonder if we would do best to leave the digital world in our pocket and just talk.
This week, a novel approach to infertility is announced, a new vaginal ring might be able to protect from HIV transmission, and the answer to preventing drug-resistant gonorrhea may be in our own immune systems.
A new report from the the Centers for Disease Control and Prevention warns of a post-antibiotic era in which none of the drugs we have work on gonorrhea and there are no new options.
A clinical trial found that two new combinations of existing drugs can cure gonorrhea, but is this enough to combat the possibility of an outbreak of antibiotic-resistant gonorrhea?